HbA1c News and Research

RSS

Pregnant women with type 1 diabetes are at greater risk of preterm birth

Pregnant women with type 1 diabetes are at increased risk of delivering their baby prematurely. The risk increases as blood sugar levels rise, however women who maintain the recommended levels also risk giving birth prematurely.

23 Apr 2019

Hemoglobin A1c blood test does not detect diabetes in most patients, shows study

The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes, but it is actually unable to detect the disease in most patients, according to a new study presented Saturday, March 23, at a news conference at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.

25 Mar 2019

Routine cardiovascular screenings identify diabetes, high cholesterol in middle school kids

A pilot study of 45 middle school kids shows that more than a third of those screened had abnormal levels of blood sugar or high cholesterol. Two had blood sugar levels in the diabetes range.

15 Mar 2019

Intense weight loss with the soups and shakes could reverse type 2 diabetes

A new study looking at the long term effects of losing substantial amounts of weight has found that it could reverse type 2 diabetes in more than a third of the patients. With the rising epidemic of obesity and type 2 diabetes around the world, this could be an important finding.

6 Mar 2019

New study analyzes health outcomes of switching patients from analog to human insulin

In the United States, the drug price for insulin has skyrocketed over the last two decades. While the price has increased for all forms of insulin, newer, "analog" insulin medications such as glargine and lispro have become especially expensive.

30 Jan 2019

Study: Only a minority of patients in the U.S. with type 1 diabetes achieve treatment goals

A new study has shown that only a minority of patients in the U.S. with type 1 diabetes achieve target levels of hemoglobin A1c, a measure of blood glucose management over time.

23 Jan 2019

Two hour gap between dinner and sleep is overrated says Japanese research

We have been advised to take a light dinner and leave a gap of at least two hours between dinner and bed time in order to maintain a healthy body weight. Now, new research suggests that this is not really necessary. The study results appear in the latest issue of the journal BMJ Nutrition, Prevention and Health.

22 Jan 2019

Short interval between last meal of the day and bedtime may not affect blood glucose levels

Leaving a two-hour gap between the last meal of the day and bedtime doesn't seem to be associated with any discernible difference in blood glucose levels among healthy adults over the long term, suggests Japanese research published in the online journal BMJ Nutrition, Prevention & Health.

22 Jan 2019

Statins associated with low risk of side effects

The cholesterol-lowering drugs called statins have demonstrated substantial benefits in reducing the risk of heart attacks and strokes caused by blood clots (ischemic strokes) in at-risk patients.

10 Dec 2018

Many people at risk of heart disease and stroke have excess abdominal fat

Nearly two-thirds of people who are at high risk of cardiovascular disease and stroke have excess fat around the middle of the body (central obesity), according to findings from the European Society of Cardiology (ESC) EUROASPIRE V survey.

7 Dec 2018

Study highlights prevalence of regional disparities in the treatment of type 1 diabetes

How the autoimmune disease type 1 diabetes is treated also depends on where the patients live in Germany.

29 Nov 2018

Prevalence of metabolic health found to be very low among American adults

A new study found that the prevalence of metabolic health is very low among American adults, even among those who have normal weight.

28 Nov 2018

Small-area-based open data can help in cost-effective health care service planning

When assessing the effects of socioeconomic status on health inequalities or outcomes of care, it is worthwhile to use small-area-based open data instead of individual SES information, a new study from the University of Eastern Finland shows.

26 Nov 2018

Diabetes medication reduces risk of heart failure hospitalization

In the largest trial to date to assess cardiovascular outcomes for an important class of diabetes medications, researchers have found that dapagliflozin markedly reduced the risk of hospitalization for heart failure in a broad population of patients with diabetes.

12 Nov 2018

Addressing chronic diseases could save tens of billions of dollars in healthcare costs annually

As Americans head to the polls this coming Tuesday, a top issue for all voters is the rising cost of healthcare. A new report has found that addressing chronic diseases, and in particular diabetes, could save tens of billions of dollars in healthcare costs annually.

2 Nov 2018

Treating gum disease could help people with Type 2 diabetes manage their blood glucose levels

A study funded by Diabetes UK has found that treating periodontitis (gum disease) could help people with Type 2 diabetes manage their blood glucose levels, and may reduce their risk of diabetes-related complications.

25 Oct 2018

EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring

EKF, announces it will be launching its new Lactate Scout 4 hand-held lactate analyzer for fast and accurate sports performance monitoring.

From EKF Diagnostics 23 Oct 2018

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.

17 Oct 2018

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the rates of remission of high blood sugar.

4 Oct 2018

Closed-loop insulin delivery improves blood sugar control in type 1 diabetes

A study has shown that hybrid day-night closed-loop insulin delivery systems are the most effective way of controlling blood sugar levels in type 1 diabetes.

3 Oct 2018